chr1-218424986-C-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001135599.4(TGFB2):​c.595-9096C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.331 in 152,054 control chromosomes in the GnomAD database, including 9,053 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.33 ( 9053 hom., cov: 32)

Consequence

TGFB2
NM_001135599.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0170

Publications

7 publications found
Variant links:
Genes affected
TGFB2 (HGNC:11768): (transforming growth factor beta 2) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGF-beta family members. Disruption of the TGF-beta/SMAD pathway has been implicated in a variety of human cancers. A chromosomal translocation that includes this gene is associated with Peters' anomaly, a congenital defect of the anterior chamber of the eye. Mutations in this gene may be associated with Loeys-Dietz syndrome. This gene encodes multiple isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Aug 2016]
TGFB2 Gene-Disease associations (from GenCC):
  • familial thoracic aortic aneurysm and aortic dissection
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Loeys-Dietz syndrome 4
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.682 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001135599.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TGFB2
NM_003238.6
MANE Select
c.511-9096C>G
intron
N/ANP_003229.1
TGFB2
NM_001135599.4
c.595-9096C>G
intron
N/ANP_001129071.1
TGFB2
NR_138148.2
n.1877-9096C>G
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TGFB2
ENST00000366930.9
TSL:1 MANE Select
c.511-9096C>G
intron
N/AENSP00000355897.4
TGFB2
ENST00000366929.4
TSL:1
c.595-9096C>G
intron
N/AENSP00000355896.4
TGFB2
ENST00000488793.1
TSL:3
n.175-9096C>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.331
AC:
50220
AN:
151936
Hom.:
9041
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.350
Gnomad AMI
AF:
0.356
Gnomad AMR
AF:
0.445
Gnomad ASJ
AF:
0.307
Gnomad EAS
AF:
0.702
Gnomad SAS
AF:
0.347
Gnomad FIN
AF:
0.304
Gnomad MID
AF:
0.294
Gnomad NFE
AF:
0.269
Gnomad OTH
AF:
0.333
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.331
AC:
50269
AN:
152054
Hom.:
9053
Cov.:
32
AF XY:
0.337
AC XY:
25018
AN XY:
74310
show subpopulations
African (AFR)
AF:
0.350
AC:
14520
AN:
41478
American (AMR)
AF:
0.445
AC:
6800
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.307
AC:
1067
AN:
3470
East Asian (EAS)
AF:
0.701
AC:
3615
AN:
5156
South Asian (SAS)
AF:
0.345
AC:
1668
AN:
4830
European-Finnish (FIN)
AF:
0.304
AC:
3213
AN:
10564
Middle Eastern (MID)
AF:
0.286
AC:
84
AN:
294
European-Non Finnish (NFE)
AF:
0.269
AC:
18269
AN:
67978
Other (OTH)
AF:
0.336
AC:
708
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1630
3259
4889
6518
8148
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
490
980
1470
1960
2450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.301
Hom.:
894
Bravo
AF:
0.346
Asia WGS
AF:
0.457
AC:
1589
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
5.7
DANN
Benign
0.77
PhyloP100
0.017
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4846478; hg19: chr1-218598328; API